Bulent Aydogan, PhD

High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT).
High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT). Eur J Haematol. 2024 Jul; 113(1):110-116.
PMID: 38566462

Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
Corrigendum: Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models. Front Med (Lausanne). 2023; 10:1339872.
PMID: 38116039

Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models.
Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models. Front Med (Lausanne). 2023; 10:1269689.
PMID: 37904839

Editorial: Total marrow irradiation.
Editorial: Total marrow irradiation. Front Oncol. 2023; 13:1240530.
PMID: 37538119

An Efficient Multi-Scale Fusion Network for 3D Organs at Risk (OARs) Segmentation.
An Efficient Multi-Scale Fusion Network for 3D Organs at Risk (OARs) Segmentation. Annu Int Conf IEEE Eng Med Biol Soc. 2023 07; 2023:1-4.
PMID: 38082949

A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
PMID: 35851593

Impact of respiratory motion on lung dose during total marrow irradiation.
Impact of respiratory motion on lung dose during total marrow irradiation. Front Oncol. 2022; 12:924961.
PMID: 36330489

Knowledge-based planning for multi-isocenter VMAT total marrow irradiation.
Knowledge-based planning for multi-isocenter VMAT total marrow irradiation. Front Oncol. 2022; 12:942685.
PMID: 36267964

A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
Tran MC, Hasan Y, Wang AY, Yenice KM, Partouche J, Stock W, Larson RA, Kosuri S, LaBelle JL, Kline J, Riedell PA, Artz AS, Weichselbaum RR, Bishop MR, Aydogan B, Liu H. A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2022 Jul 18.
PMID: 35851593

Subacute thyroiditis during the COVID-19 pandemic: a prospective study.
Subacute thyroiditis during the COVID-19 pandemic: a prospective study. J Endocrinol Invest. 2022 Apr; 45(4):865-874.
PMID: 35023078